Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A randomized comparison of triptorelin and tamoxifen as treatment of progressive ovarian cancer.

× No keyword cloud information.

10 in total

1. The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer.

Authors: Hakan Karagol; Pinar Saip; Kazim Uygun; Murat Caloglu; Yesim Eralp; Faruk Tas; Adnan Aydiner; Erkan Topuz
Journal: Med Oncol Date: 2007 Impact factor: 3.064

2. Antiestrogen therapy in recurrent ovarian cancer resulting in 28 months of stable disease: a case report and review of the literature.

Authors: Rajul Kothari; Peter Argenta; Jeffrey Fowler; Jori Carter; William Shimp
Journal: Arch Oncol Date: 2010

Review 3. Revisiting the role of antiandrogen strategies in ovarian cancer.

Authors: Dionysis Papadatos-Pastos; Konstantin J Dedes; Johann S de Bono; Stanley B Kaye
Journal: Oncologist Date: 2011-09-23

Review 4. Tamoxifen for relapse of ovarian cancer.

Authors: Chris Williams; Iveta Simera; Andrew Bryant
Journal: Cochrane Database Syst Rev Date: 2010-03-17

Review 5. Hormone response in ovarian cancer: time to reconsider as a clinical target?

Authors: Francesmary Modugno; Robin Laskey; Ashlee L Smith; Courtney L Andersen; Paul Haluska; Steffi Oesterreich
Journal: Endocr Relat Cancer Date: 2012-11-09 Impact factor: 5.678

Review 6. New insights on the role of hormonal therapy in ovarian cancer.

Authors: Fiona Simpkins; Arlene Garcia-Soto; Joyce Slingerland
Journal: Steroids Date: 2013-02-08 Impact factor: 2.668

Review 7. Estrogen receptors and human disease.

Authors: Bonnie J Deroo; Kenneth S Korach
Journal: J Clin Invest Date: 2006-03 Impact factor: 14.808

Review 8. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.

Authors: Rekha Wuntakal; Srividya Seshadri; Ana Montes; Geoff Lane
Journal: Cochrane Database Syst Rev Date: 2016-06-29

Review 9. Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review).

Authors: Hongyi Li; Yu Liu; Yang Wang; Xia Zhao; Xiaorong Qi
Journal: Oncol Rep Date: 2021-08-26 Impact factor: 3.906

Review 10. Estrogen, progesterone and epithelial ovarian cancer.

Authors: Shuk-Mei Ho
Journal: Reprod Biol Endocrinol Date: 2003-10-07 Impact factor: 5.211

10 in total